Digital Content 
NEWS #PharmaBuzz
13 Sep 2018
// John Carroll ENDPTS
https://endpts.com/acordas-awful-no-good-just-plain-bad-week-gets-worse-as-fda-hands-execs-another-delay-on-inbrija-battered-shares-tumble-again/?utm_medium=email&utm_campaign=564%20Thu%2091318%20Genentech%20science%20crew%20spotlights%20a%20breakthrough%20SEC%20alleges%20hedge%20fund%20player%20lied%20in%20biotech%20short%20attack&utm_content=564%20Thu%2091318%20Genentech%20science%20crew%20spotlights%20a%20breakthrough%20SEC%20alleges%20hedge%20fund%20player%20lied%20in%20biotech%20short%20attack+CID_c4f98919d8f5ac4097aa265dd3bfc0c5&utm_source=ENDPOINTS%20emails&utm_term=Acordas%20awful%20no%20good%20just%20plain%20bad%20week%20gets%20worse%20as%20FDA%20hands%20execs%20another%20delay%20on%20Inbrija%20%20battered%20shares%20tumble%20again
11 Sep 2018
// Jan Wolfe CNBC
https://www.cnbc.com/2018/09/10/reuters-america-update-1-u-s-appeals-court-invalidates-acorda-patents-on-ms-drug.html
10 Sep 2018
// John Carroll ENDPTS
https://endpts.com/acorda-shares-crater-after-appeals-court-dashes-remaining-hopes-for-salvaging-ampyra-patents/
06 Aug 2018
// Carly Helfand FIERCE PHARMA
https://www.fiercepharma.com/pharma/acorda-inks-mylan-settlement-pact-as-it-waits-for-ampyra-appeal-news
05 Jan 2018
// John Carroll END POINTS
https://endpts.com/after-resisting-a-push-to-the-auction-block-acorda-preps-for-a-sale-and-shares-shoot-up-report/
02 Sep 2017
// John Carroll ENDPTS
https://endpts.com/troubled-acorda-hurries-to-bar-the-door-against-a-takeover-attempt/
LOOKING FOR A SUPPLIER?
Share